LUCENCE/A*STAR
16.6.2020 12:02:06 CEST | Business Wire | Press release
Molecular diagnostics company Lucence and the Agency for Science, Technology and Research (A*STAR) today announced study results indicating that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection. This proprietary reagent also stabilizes viral RNA at room temperature for up to one week. Together, these properties enable accessible, non-invasive, and safe sample collection via saliva, which is critical to scaling cost-effective testing worldwide. The reagent used in Lucence’s SAFER Sample kit was invented at A*STAR’s Institute of Bioengineering and Nanotechnology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200616005320/en/
The SAFER Sample Collection Kit is registered as a Class A medical device with the Health Sciences Authority of Singapore and is an easy-to-use saliva collection kit that comes with a bottle of stabilization fluid to be mixed with the sample at the point of collection, keeping viral RNA stable at room temperature for up to one week. While conventional viral transport media requires cold-chain transport to prevent sample degradation, which can drive up associated costs and limit testing geography, SAFER Sample’s proprietary media means samples can be transported to a lab without the need for chilling.
In this new study, Lucence and A*STAR demonstrated that the proprietary reagent provided with the SAFER Sample kit also achieved complete inactivation of SARS-CoV-2 virus within 45 seconds of exposure. Conventional viral transport media used for collecting nasal and nasopharyngeal swab specimens do not inactivate viral samples, creating risk of exposure to active virus during transportation from collection sites to the laboratory and higher costs associated with biohazard handling procedures. SAFER Sample kit’s viral inactivation capabilities could mean enhanced safety and reduced risk of exposure for any individual involved in the collection, transport, and testing processes. Lucence worked with the Diagnostics Development (DxD) Hub of A*STAR to evaluate the virucidal properties of the SAFER Sample reagent. Duke-NUS Medical School was also engaged to perform the virucidal work with SARS-CoV-2 virus.
Mass testing and screening of large populations is key to reduce the risk of COVID-19 transmission, morbidity and mortality. By eliminating obstacles to sample integrity and, now, biosafety through viral inactivation, the SAFER Sample kit could expand testing geography, decrease associated costs, and increase efficiency of testing at scale compared to approaches utilizing conventional viral transport media.
Studies with clinical partners are ongoing to further evaluate the performance of the SAFER Sample kit. With the support of DxD Hub in verification and validation, quality management system (QMS), and regulatory registration, Lucence has received ISO13485:2016 certification for its QMS which controls the processes for the manufacture of the SAFER Sample Saliva Specimen Collection Kit.
About Lucence
Lucence is a precision oncology company that makes state-of-the-art, highly sensitive liquid biopsy tests for disease detection and treatment selection. Lucence is headquartered in Palo Alto and Singapore, and its services are delivered worldwide through an accredited central laboratory. Visit www.lucence.com for more information.
About the Agency for Science, Technology and Research (A*STAR)
The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector R&D agency, spearheading economic-oriented research to advance scientific discovery and develop innovative technology. Through open innovation, we collaborate with our partners in both the public and private sectors to benefit society. As a Science and Technology Organisation, A*STAR bridges the gap between academia and industry. Our research creates economic growth and jobs for Singapore, and enhances lives by contributing to societal benefits such as improving outcomes in healthcare, urban living, and sustainability. We play a key role in nurturing and developing a diversity of talent and leaders in our Agency and research entities, the wider research community and industry. A*STAR’s R&D activities span biomedical sciences and physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, visit www.a-star.edu.sg . For information on the Diagnostics Development (DxD) Hub, visit https://www.a-star.edu.sg/accelerate/innovation-offerings/diagnostics-development-hub
Follow us on Facebook | LinkedIn | Instagram | YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20200616005320/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hightouch Names Matthew Lubeck General Manager, EMEA7.10.2026 15:40:00 CEST | Press release
Marketing technology veteran will lead Hightouch’s growth across EMEA Hightouch, the leader in data and AI for marketing, has named Matthew Lubeck General Manager, EMEA. Based in London, Lubeck will lead all of Hightouch's go-to-market functions across EMEA as the company helps brands in the region move to agentic marketing. Hightouch already has a strong foundation in Europe, with offices in London and Paris, and native-speaking teams in France, the German-speaking markets, Italy, the Nordics, Benelux, and the Middle East. It supports EU data residency and runs inside each customer's own data warehouse, so customer data never has to be copied into another platform. Brands across the region use Hightouch, including Accor, HelloFresh, Currys, Telenor, Salomon, Bolt, Nando's, and Depop. The company is also growing its Middle East presence, with a new team in Dubai focused on the UAE and Saudi Arabia. Lubeck's appointment follows more than 100 percent growth for Hightouch in each of the p
Lenovo Announces Tech World @ CES 2027: Defining the Next Era of Hybrid AI7.10.2026 15:01:00 CEST | Press release
Lenovo Chairman and CEO Yuanqing Yang to unveil how Hybrid AI turns data into value for every individual and enterprise during CES Keynote at Sphere Lenovo, the global technology powerhouse, today announced that its annual global innovation event will return to CES® 2027 in Las Vegas. Hosted at Sphere and part of the CES Keynote lineup, Tech World will bring together a visionary lineup of speakers and breakthrough innovations with a first-of-its-kind immersive technology and music experience. As well as unveiling the latest in Lenovo’s innovations, Tech World will unite global technology leaders and leading voices on stage to discuss the future of AI. Together, they will explore how hybrid AI can empower people and unlock new possibilities for business and society. As demand grows for responsible AI leadership, the event will provide a defining moment at the start of 2027 to consider AI’s role in unlocking human potential, sustaining the planet, and driving global progress. “AI is ente
NTT DATA Opens AI Factory Munich Where Clients Can Validate their AI in a Live Environment7.10.2026 15:00:00 CEST | Press release
Helping clients move AI from pilots to production in a live, production-grade environmentEnabling organizations to test AI they own and control against their own use cases before making investment decisionsBringing together NTT DATA’s consulting, data, AI, infrastructure, security, operations and managed services expertise with leading technology partners including Dell Technologies and NVIDIA NTT DATA, a global leader in AI, digital business and technology services, today opened the NTT DATA AI Factory Munich, a real-world environment where clients can test how their AI applications will perform at scale before they invest in broad deployments. Unlike a traditional AI demonstration or innovation lab, the AI Factory Munich operates within a live data center environment (NTT Global Data Centers' Munich 2 Data Center), allowing clients to evaluate AI workloads against the infrastructure, security, data, governance and operational requirements they will face in production. AI deployments
Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment7.10.2026 15:00:00 CEST | Press release
Founded by serial entrepreneur and CEO, Yann Fleureau, and former AI research leader at Novartis and Owkin Eric Durand, Rivercell aims to generate high-resolution data on how human cells respond to treatments at scale and train AI models to predict their effects, ultimately accelerating the discovery and development of cures. Seed round led by HV, with participation from HCVC, Alven, and Bpifrance Digital Venture, to scale Rivercell's proprietary data engine and automated wet lab, and ship the first AI world model of the cell trained on a new data substrate. Eric Durand joins as co-founder and Chief Science Officer (CSO). At Novartis, he successfully supported around 300 drug programs before building Owkin’s data science team as Chief Data Science Officer, giving him first-hand insight into the data that today's bio world models are missing. Leading researchers in AI for biomedicine, Dr. Charlotte Bunne (EPFL) and Prof. Fabian Theis (Helmholtz Munich), join the Scientific Advisory Boar
Print Infrastructure Is the Biggest Zero Trust Gap CIOs Haven’t Closed, Survey Finds7.10.2026 14:30:00 CEST | Press release
54% of CIOs and IT leaders call the risk in their document and print workflows “known and accepted,” even as only 16% have brought print into their Zero Trust architecture Vasion today released new research revealing a security gap hiding in plain sight across enterprise IT: CIOs and IT leaders know their print environments carry risk, but print remains largely outside their Zero Trust strategies even as failures continue to disrupt business operations. According to an independent survey of 500+ enterprise CIOs and senior IT leaders commissioned by Vasion through Censuswide, 54% of respondents describe their print environment as “actively managed, with known and accepted risks.” At the same time, 61% report that print or document workflow failures disrupt their business at least once a week. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007677295/en/ Print Infrastructure Is the Biggest Zero Trust Gap CIOs Haven’t Closed,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom